Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

15 trials with published results (20%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.8%

5 terminated out of 74 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

14%

10 trials in Phase 3/4

Results Transparency

30%

15 of 50 completed with results

Key Signals

15 with results91% success

Data Visualizations

Phase Distribution

58Total
Not Applicable (21)
P 1 (16)
P 2 (11)
P 3 (9)
P 4 (1)

Trial Status

Completed50
Unknown8
Not Yet Recruiting5
Active Not Recruiting5
Terminated5
Recruiting1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 50 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT07128615Phase 1Active Not RecruitingPrimary

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

NCT07430410Not ApplicableNot Yet Recruiting

Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test

NCT05202379Phase 1CompletedPrimary

CC-42344 Safety Study in Healthy Participants

NCT06567860Phase 4CompletedPrimary

Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

NCT07330986Completed

Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China

NCT07308158CompletedPrimary

Covid Flu A/B and RSV 4 in 1 Diagnostic Test

NCT07190131Completed

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

NCT07314905Phase 3Not Yet RecruitingPrimary

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

NCT07229807Phase 3Active Not RecruitingPrimary

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

NCT07229820Phase 3Active Not RecruitingPrimary

Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A

NCT06656026Phase 2CompletedPrimary

Pharmacokinetics,Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

NCT07217639Not ApplicableNot Yet Recruiting

Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings

NCT06160531Phase 2CompletedPrimary

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

NCT06008457Completed

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

NCT06734741Completed

Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use

NCT04896853Phase 1Active Not Recruiting

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

NCT06191393Not ApplicableCompleted

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

NCT05728970Completed

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites

NCT02342249Phase 2CompletedPrimary

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

NCT03376321Phase 3TerminatedPrimary

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Scroll to load more

Research Network

Activity Timeline